These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3209529)

  • 41. Pharmacokinetics of ciprofloxacin in the elderly.
    Bayer A; Gajewska A; Stephens M; Stark JM; Pathy J
    Respiration; 1987; 51(4):292-5. PubMed ID: 3659579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sex-related differences in the pharmacokinetics of oral ciprofloxacin.
    Overholser BR; Kays MB; Forrest A; Sowinski KM
    J Clin Pharmacol; 2004 Sep; 44(9):1012-22. PubMed ID: 15317829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
    Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W
    Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens.
    Anadón A; Martínez-Larrañaga MR; Iturbe J; Martínez MA; Díaz MJ; Frejo MT; Martínez M
    Res Vet Sci; 2001 Oct; 71(2):101-9. PubMed ID: 11883887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid.
    Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Jaehde U; Reiter A; Naber KG; Rodamer M; Sörgel F
    Br J Clin Pharmacol; 2010 Feb; 69(2):167-78. PubMed ID: 20233180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dose dependence of piperacillin pharmacokinetics.
    Bergan T; Williams JD
    Chemotherapy; 1982; 28(3):153-9. PubMed ID: 6212203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of intravenously administered ciprofloxacin.
    Wise R; Lockley RM; Webberly M; Dent J
    Antimicrob Agents Chemother; 1984 Aug; 26(2):208-10. PubMed ID: 6486762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers.
    Nakashima M; Kanamaru M; Uematsu T; Takiguchi A; Mizuno A; Itaya T; Kawahara F; Ooie T; Saito S; Uchida H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():133-44. PubMed ID: 3144532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transintestinal elimination of ciprofloxacin.
    Rohwedder RW; Bergan T; Thorsteinsson SB; Scholl H
    Diagn Microbiol Infect Dis; 1990; 13(2):127-33. PubMed ID: 2369809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of ciprofloxacin on the disposition of 14C-dideoxyinosine-derived radioactivity in the rat.
    Gallicano KD; Buttar HS; Moffatt JH
    Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):163-74. PubMed ID: 8321920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative oral pharmacokinetics of fleroxacin and pefloxacin.
    De Lepeleire I; Van Hecken A; Verbesselt R; Tjandra-Maga TB; De Schepper PJ
    J Antimicrob Chemother; 1988 Aug; 22(2):197-202. PubMed ID: 3141343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of a pharmacokinetic interaction between ciprofloxacin and fenbufen.
    Kamali F
    J Clin Pharm Ther; 1994 Aug; 19(4):257-9. PubMed ID: 7989405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro and in vivo ciprofloxacin pharmacokinetics in human neutrophils.
    Garraffo R; Jambou D; Chichmanian RM; Ravoire S; Lapalus P
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2215-8. PubMed ID: 1803994
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of ciprofloxacin in liver cirrhosis.
    Ruhnke M; Trautmann M; Borner K; Hopfenmüller W
    Chemotherapy; 1990; 36(6):385-91. PubMed ID: 2292201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs.
    Papich MG
    Am J Vet Res; 2012 Jul; 73(7):1085-91. PubMed ID: 22738062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of piritramide in newborns, infants and young children in intensive care units.
    Müller C; Kremer W; Harlfinger S; Doroshyenko O; Jetter A; Hering F; Hünseler C; Roth B; Theisohn M
    Eur J Pediatr; 2006 Apr; 165(4):229-39. PubMed ID: 16496200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of ciprofloxacin after single intravenous and repeat oral administration to cats.
    Albarellos GA; Kreil VE; Landoni MF
    J Vet Pharmacol Ther; 2004 Jun; 27(3):155-62. PubMed ID: 15189301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of difloxacin in goats.
    Atef M; el-Banna HA; Abd El-Aty AM; Goudah A
    Dtsch Tierarztl Wochenschr; 2002 Jul; 109(7):320-3. PubMed ID: 12161971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple-dose pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers.
    Gonzalez MA; Moranchel AH; Duran S; Pichardo A; Magana JL; Painter B; Forrest A; Drusano GL
    Antimicrob Agents Chemother; 1985 Aug; 28(2):235-9. PubMed ID: 2939794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Penetration of ciprofloxacin into human pleural fluid.
    Jacobs F; Marchal M; de Francquen P; Kains JP; Gangji D; Thys JP
    Antimicrob Agents Chemother; 1990 May; 34(5):934-6. PubMed ID: 2360834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.